Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
Related Posts
Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?
Dr Lal Path Labs shares surged after a strong Q1FY27 earnings beat, driven by higher realisations and price hikes. Brokerages including Nomura, Nuvama and JM Financial raised target prices, citing robust growth outlook, network expansion and improving margins, with continued momentum expected from diagnostics demand and strategic investments.
The Titans of Nasdaq 100: Top companies ranked by market cap
The Nasdaq-100’s largest companies continue to dominate global technology, AI, cloud computing and digital markets. Nvidia and Apple lead by market value, while Amazon tops revenue, reflecting the scale, innovation and financial strength driving the world’s biggest technology businesses.
Aastha Spintex shares to list today. Check GMP ahead of debut
The Rs 170 crore public issue has been commanding a grey market premium (GMP) of around 2% ahead of its listing. If the sentiment holds, the shares could debut near Rs 139, slightly above the IPO’s upper price band of Rs 136, signalling a muted listing gain for investors.